The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 354:1950-1951 May 4, 2006 Number 18
NextNext

Saw Palmetto for Benign Prostatic Hyperplasia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Bent, S.
-PubMed Citation
To the Editor: Bent et al. (Feb. 9 issue)1 report that 160 mg of saw palmetto taken twice daily did not improve symptoms of benign prostatic hyperplasia. The authors indicate that the fatty-acid fraction of saw palmetto may be the active ingredient of the berry extract and that most products contain 85 to 95 percent fatty acids. Since saw palmetto is available in higher doses than 160 mg, would it not be expected that the higher-dose capsules contain more of the supposed active ingredient and thus would be more effective than the 160-mg dose?


Paul R. Casner, M.D., Ph.D.
Texas . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.